Moderna Says FDA Refusal to Review mRNA Flu Vaccine Contradicts Federal Rules, Prior Guidance

The FDA’s refuse-to-file letter cited no safety or efficacy concerns for Moderna’s influenza vaccine, mRNA-1010. The company said the agency’s justification for refusing a review is inconsistent with guidance given prior to the start of Phase 3 testing. The post Moderna Says FDA Refusal to Review mRNA Flu Vaccine Contradicts Federal Rules, Prior Guidance appeared…

Read More

From Claims Payer to Care Partner: What AI Really Changes in Health Insurance, and What It Doesn’t

AI can help health plans reduce friction, speed revenue-cycle throughput, and improve member experience, but only when it is deployed with strong data discipline, modern integration patterns, and a governance model that treats AI as “augmented intelligence,” meaning powerful, assistive, and accountable. The post From Claims Payer to Care Partner: What AI Really Changes in…

Read More

Medicare Advantage’s Discipline Era — and Why the Final Rate Notice Matters More Than It Appears

The challenge for policymakers is balance: encouraging rigor without unintentionally weakening a program that now serves the majority of Medicare beneficiaries. Thoughtful rate calibration can determine whether this transition strengthens the program or strains it unnecessarily. The post Medicare Advantage’s Discipline Era — and Why the Final Rate Notice Matters More Than It Appears appeared…

Read More

2026: A Year for Reimagining Healthcare’s Safety Net

By JEFF BRANDES To say healthcare’s safety net experienced tectonic shifts in 2025 would be an understatement. The rapid introduction of multiple and massive policy shifts left many healthcare leaders reeling with more questions than answers. As the industry turns the corner into 2026 and the dust begins to settle, it’s time for stakeholders to…

Read More